Specialists from different disciplines work together under the umbrella of the Brain Cancer Center to provide patients and referring physicians with uncomplicated access to highly qualified brain tumor diagnostics and treatment. The first step is a rapid and comprehensive diagnosis, followed by the presentation of the findings to our interdisciplinary Cancer Board. The available treatment methods are discussed and a therapy approach adapted to the patient’s expectations is developed.

 

The focus is on providing patients with comprehensive information and care; in addition to medical treatment, this includes a wide range of other therapy options such as psychological support and physiotherapy, occupational therapy, and speech therapy.

Zunächst geht es um eine zügige und umfassende Diagnostik, daran schliesst sich die Vorstellung der erhobenen Befunde in unserem interdisziplinären Tumorboard an. In diesem werden die zur Verfügung stehenden Behandlungsmodalitäten diskutiert und ein an die Vorstellungen der Patientin, des Patienten angepasstes Therapiekonzept erarbeitet.

 

Im Zentrum steht die umfassende Information und Betreuung der Patientin, des Patienten; dies beinhaltet im weiteren Krankheitsverlauf neben der ärztlichen Behandlung auch ein breites Spektrum an zusätzlichen Therapieangeboten wie z.B. psychologische Begleitung sowie physio-, ergo- und logotherapeutische Massnahmen.

In principle, we differentiate between tumors that originate from the brain tissue itself (primary tumors) and tumors of brain appendages, such as the meninges, as well as colonies of other tumors (metastases) in the brain. This distinction is important because it results in fundamental differences in treatment options and individual prognoses.

This type of primary brain tumor is characterized by rapid and destructive growth in the brain. Those affected are usually of middle to advanced age. Symptoms are often acute failure of brain function, such as speech or motor function.

This primary brain tumor is characterized by slow growth, usually over a period of many years. This may cause brain function to shift to other areas of the brain (brain «plasticity»). Younger patients and middle-aged patients are often affected, with epileptic seizures being the first symptom.

These tumors originate from the hard meninges of the brain, are usually slow-growing and do not infiltrate the brain. As a result, they can often be completely removed surgically. Mostly, patients of middle to advanced age are affected, and this is occasionally a random finding in the context of the investigation of other diseases. The range of symptoms is diverse and includes neurological deficits, epileptic seizures and personality changes.

Tumors from other organs can also settle settle as secondary tumors in the brain. Brain metastases can by solitary, in one place, or multiple, in several places in the brain.  This distinction is important for deciding which therapy methods are promising and suitable.

These tumors often become conspicuous in the longer term with deterioration of vision and/or hormonal disorders, for example by causing changes in body proportions or milk flow in non-lactating women.  Acute problems may occur, for example, due to bleeding within the tumor, which can cause rapid vision loss. 

 

Often these are vestibular schwannoma, i.e. benign tumors that originate from the balance nerves and grow into the base of the skull. Symptoms are often one-sided hearing reduction or even hearing loss, tinnitus caused by the anatomical proximity to the auditory nerve, and/or balance disorders and dizziness.

 

The most common form of treatment is surgery. Radiation and chemotherapy are also available. In special cases, there are also other treatment options, such as nuclear medicine methods, alternating electric fields, etc. Due to our research activities in brain tumor research, many patients also have the opportunity to participate in a treatment study.

The aim of surgical tumor treatment is ideally the complete removal of a tumor. In cases where this is not possible, for example due to invasive tumor growth, the aim is to reduce the tumor mass as much as possible. Various electrophysiological procedures are used to protect important brain functions during surgery. In the case of certain tumors, it makes sense to remove the tumor while awake.

 

In some cases, radiotherapy is the most promising form of tumor treatment. In many cases, radiation is used after surgery to treat residual tumor tissue. Radiation can also be used to treat regenerative tumors in surgically difficult-to-access areas.

In the case of brain tumors, chemotherapy is often used in combination with radiotherapy as a follow-up treatment after surgery, especially in the case of primary brain tumors. This usually involves the use of well-tolerated substances so that chemotherapy can be done at home in the form of pills. There are various other chemotherapy approaches for regenerating tumors that can be used without prior or accompanying radiotherapy or surgery.

The diagnosis of a brain tumor entails great uncertainty for both the affected patient and their family. We attach great importance to the ongoing involvement of family members and the promotion of the individual quality of life of each patient.

 

We focus on the following points:

 

  • Close cooperation with speech therapy, occupational therapy and physiotherapy, psycho-oncology
  • Regular therapy meetings involving all specialists
  • The nursing team is specially trained in pain, aphasia, communication and palliative care

 

Leitung

39a8310e-8595-4d71-9363-f5a3f52dcf2d

PD Dr. Dominik Cordier

Leitender Arzt

Neurochirurgie

Show profile

04a36b53-5ddf-4b57-93d1-e1a07c5b488c

PD Dr. Markus Gross

Stv. Chefarzt

Radioonkologie

Stv. Leiter Gynäkologisches Tumorzentrum, Stv. Leiter Hirntumorzentrum

Show profile

Leitungsgremium

f1598dff-4bc7-4990-a387-45a46f50c37d

Prof. Emanuel Christ

Leitender Arzt

Endokrinologie, Diabetologie & Metabolismus

Show profile

7a8eba98-afaa-4fe4-abdf-6d3c7b5f0f51

Prof. Dr. rer. nat. Sven Cichon

Leiter

Medizinische Genetik

d402c623-1d24-4445-9600-dd25d7c857d0

Dr. Sandra Eckstein

Leitende Ärztin

Palliative Care

a95c232e-a32b-4cf8-9e6e-db5e305f5117

Sabrina Elia, M.Sc.

Psychologin

Psychosomatik

Show profile

f819a43b-45ab-4454-9a44-2e043ad71cb2

Prof. Stephan Frank

Leitender Arzt und Fachbereichsleiter Neuro- und Ophthalmopathologie

Pathologie

Mitglied Tumorzentrum , Neuro- und Muskelpathologie, Molekularpathologie

cb8f669b-928d-4e43-bfab-6ce8799c8380

Prof. Jörg Halter

Leitender Arzt

Hämatologie

711ab237-1769-4f1c-a5a8-de6344d45e56

Prof. Heinz Läubli

Leitender Arzt / Leitung Klinische Forschung

medizinische Onkologie FMH, allgemeine Innere Medizin FMH, Mitglied Tumorzentrum, Forschungsgruppenleiter Tumorimmuntherapie, DBM und DKF 

Hirntumore, Hauttumore, Thoraxtumore, Immuntherapie, Krebsimmunologie

Show profile

92d98ef0-7ba4-4a1d-95ca-a7077f3bb956

Jerry Lavorgna

Leiter IPM – Sozialdienst

Integriertes Patientenmanagement

b109c9d5-59d9-4530-bfbb-45dc6eb07124

Dr. Johanna Lieb

Kaderärztin, stv. Leitung Neuroradiologie, Mitglied Tumor- und MS-Zentrum

Radiologie und Nuklearmedizin

e611fa7b-2ec7-4f67-b164-8303f5e67829

PD Dr. Johannes Lorscheider

Oberarzt

Neurologie

Stv. Leiter Neurologische Poliklinik, Multiple Sklerose Zentrum

Show profile

2ec24a0c-db83-4599-8c21-ee6e2859d761

Prof. Luigi Mariani

Chefarzt und Stv. Klinikleiter

Neurochirurgie

Show profile

a1135ef1-deef-4082-a528-0ed735cae9bc

Prof. Dr. phil. Dr. med Damian Wild

Leitung Nuklearmedizin

Radiologie und Nuklearmedizin

Radiologie und Nuklearmedizin, Zentrum für neuroendokrine und endokrine Tumore, Wirbelsäulenzentrum

Show profile

6b9b96d1-56aa-4fcd-91a0-16dc78823f14

Doris Würmli

Pflegeexpertin

Chirurgie B3.3

Wirbelsäulenzentrum

Kontakt

Sekretariat
Tel. +41 61 265 39 05

Zertifizierung